author-photo

Ida Holme Håkonsson

Novo Nordisk

5

Papers

37

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial

2020 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (14)
Efficacy and safety of once-weekly somapacitan in adult growth hormone deficiency (AGHD) confirmed in a 53-week REAL-1 trial extension

2019
Show All
- Source
- Cite
- Save
Citations (1)
SAT-LB074 Efficacy and Safety of Once-weekly Somapacitan in Adult Growth Hormone Deficiency (AGHD) Confirmed in a 53‑week Real 1 Trial Extension

2019 Journal of the Endocrine Society
Show All
- Source
- Cite
- Save
Citations (1)